To investigate the role of the NF-κB signaling pathway in B[a]P-induced HCC metastasis, a specific inhibitor of IκBα, BAY11-7085, was utilized to block NF-κB signaling (Figure 5D). Here, NFKB1 is linked to hepatocellular carcinoma.